-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Theriva Biologics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
- Theriva Biologics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 1.13M shares, a 66.4% increase year-over-year.
- Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 16.1M shares, a 5.09% increase from 2022.
- Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.3M shares, a 25.8% increase from 2021.
- Theriva Biologics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 12.2M shares, a 35.9% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)